PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,760,112 | -46.2% | 57,370 | -29.7% | 0.01% | -40.9% |
| Q2 2023 | $3,270,954 | -0.7% | 81,631 | +1.2% | 0.02% | -8.3% |
| Q1 2023 | $3,293,204 | +2.2% | 80,696 | -3.3% | 0.02% | -4.0% |
| Q4 2022 | $3,222,893 | +71936.1% | 83,473 | -0.8% | 0.02% | -34.2% |
| Q3 2022 | $4,474 | -99.9% | 84,111 | 0.0% | 0.04% | -9.5% |
| Q2 2022 | $4,904,000 | -22.7% | 84,111 | +1.2% | 0.04% | +7.7% |
| Q1 2022 | $6,345,000 | +16.2% | 83,140 | -8.4% | 0.04% | +34.5% |
| Q4 2021 | $5,459,000 | +8.4% | 90,730 | +0.9% | 0.03% | 0.0% |
| Q3 2021 | $5,038,000 | -7.7% | 89,960 | 0.0% | 0.03% | -12.1% |
| Q2 2021 | $5,459,000 | -13.0% | 89,960 | +0.4% | 0.03% | -17.5% |
| Q1 2021 | $6,278,000 | +9.2% | 89,570 | -6.8% | 0.04% | -9.1% |
| Q4 2020 | $5,751,000 | +1.1% | 96,100 | +1.6% | 0.04% | -4.3% |
| Q3 2020 | $5,689,000 | +15.1% | 94,630 | +0.5% | 0.05% | 0.0% |
| Q2 2020 | $4,943,000 | +57.7% | 94,200 | +0.7% | 0.05% | +27.8% |
| Q1 2020 | $3,135,000 | -26.0% | 93,500 | 0.0% | 0.04% | +38.5% |
| Q4 2019 | $4,236,000 | +5.0% | 93,500 | -11.8% | 0.03% | -3.7% |
| Q3 2019 | $4,035,000 | – | 106,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |